Patent · US Active

Processes for preparing pyrazolo[3,4-d]pyrimidine ethers

US7425630B2 · kind B2 · utility

10Cited by
2References
74Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2006
Grant dateSep 16, 2008
Priority date
Expiry dateJul 10, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to processes for preparing pyrazolo[3,4-d]pyrimidine ether compounds that are modulators of glucose metabolism and therefore useful in the treatment of metabolic disorders such as diabetes and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.